Victory Capital Management Inc Deciphera Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$7.7 - $37.13 $120,066 - $578,968	-15,593 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$26.46 - $37.15 $4,048 - $5,683	153 Added 0.99%	15,593 $530,000
Q2 2021 Aug 03, 2021	SELL	$32.73 - $47.95 $20,161 - $29,537	-616 Reduced 3.84%	15,440 $565,000
Q1 2021 May 04, 2021	SELL	$40.39 - $56.73 $44,469 - $62,459	-1,101 Reduced 6.42%	16,056 $720,000
Q4 2020 Feb 01, 2021	SELL	$51.77 - $66.18 $722,605 - $923,740	-13,958 Reduced 44.86%	17,157 $979,000

Q3 2020 Nov 09, 2020	SELL	$43.8 - $58.16 $603,520 - $801,386	-13,779 Reduced 30.69%	31,115 $1.6 Million
Q2 2020 Aug 07, 2020	SELL	$37.05 - $65.03 $7,261 - $12,745	-196 Reduced 0.43%	44,894 $2.68 Million
Q1 2020 May 04, 2020	BUY	$33.63 - $69.4 $124,128 - $256,155	3,691 Added 8.92%	45,090 $1.86 Million
Q4 2019 Feb 06, 2020	BUY	$31.7 - $69.93 $44,982 - $99,230	1,419 Added 3.55%	41,399 $2.58 Million
Q4 2019 Feb 04, 2020	BUY	$31.7 - $69.93 $152,445 - $336,293	4,809 Added 13.67%	39,980 $2.5 Million
Q3 2019 Nov 12, 2019	BUY	$19.95 - $38.85 $687,536 - $1.34 Million	34,463 Added 4867.66%	35,171 $1.19 Million
Q4 2018 Feb 05, 2019	SELL	$19.08 - $36.14 $2,575 - $4,878	-135 Reduced 16.01%	708 $15,000
Q3 2018 Nov 01, 2018	BUY	$33.57 - $42.1 $3,726 - $4,673	111 Added 15.16%	843 $33,000
Q2 2018 Aug 02, 2018	BUY	$20.06 - $44.95 $14,683 - $32,903	732 New	732 $29,000
Q4 2017 Feb 01, 2018	SELL	$16.54 - $24.2 $992,400 - $1.45 Million	-60,000 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$17.65 - $18.99 $1.06 Million - $1.14 Million	60,000	60,000 $1.14 Million

178

59.6M

5.3K

27.6K

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.